Cohen, C., Molina, J., Cahn, P., Clotet, B., Fourie, J., Grinsztejn, B., . . . Boven, K. (2010). Pooled week 48 safety and efficacy results from the ECHO and THRIVE phase III trials comparing TMC278 vs EFV in treatment-naïve, HIV-1-infected patients. The International AIDS Society.
शिकागो स्टाइल उद्धरणCohen, C., et al. Pooled Week 48 Safety and Efficacy Results From the ECHO and THRIVE Phase III Trials Comparing TMC278 Vs EFV in Treatment-naïve, HIV-1-infected Patients. The International AIDS Society, 2010.
एमएलए उद्धरणCohen, C., et al. Pooled Week 48 Safety and Efficacy Results From the ECHO and THRIVE Phase III Trials Comparing TMC278 Vs EFV in Treatment-naïve, HIV-1-infected Patients. The International AIDS Society, 2010.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.